| Literature DB >> 25006052 |
Andrew Appelboam1, James Gagg2, Adam Reuben1.
Abstract
Patients with attacks of re-entrant supraventricular tachycardia (SVT) frequently present to the emergency department (ED). The Valsalva manoeuvre (VM) is the most effective and safe vagal manoeuvre and advocated as the first-line treatment in stable patients but has a relatively low cardioversion success rate. Improving its efficacy would reduce patients' exposure to the side effects and complications of second-line treatments and has other potential benefits. We describe a modification to the VM, which is currently being studied, and present the case of a 23-year-old patient who was successfully treated with this modified VM after a previous near-fatal complication of direct current (DC) cardioversion. 2014 BMJ Publishing Group Ltd.Entities:
Mesh:
Year: 2014 PMID: 25006052 PMCID: PMC4091469 DOI: 10.1136/bcr-2013-202699
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X